FSIS ISSUES PUBLIC HEALTH ALERT FOR MEAT AND POULTRY

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2022
517
FSIS ISSUES PUBLIC HEALTH ALERT FOR MEAT AND POULTRY TAQUITOS AND CHIMICHANGAS CONTAINING FDA-REGULATED DICED GREEN CHILIES THAT HAVE BEEN RECALLED DUE TO POSSIBLE FOREIGN MATTER CONTAMINATION

Washington, D.C., Aug. 01, 2020 (GLOBE NEWSWIRE) --

Public Health Alert
  Congressional and Public Affairs Veronika Pfaeffle (202) 720-9113 FSISpress@usda.gov
  FSIS ISSUES PUBLIC HEALTH ALERT FOR MEAT AND POULTRY TAQUITOS AND CHIMICHANGAS CONTAINING FDA-REGULATED DICED GREEN CHILIES THAT HAVE BEEN RECALLED DUE TO POSSIBLE FOREIGN MATTER CONTAMINATION     WASHINGTON, Aug. 1, 2020 – The U.S. Department of Agriculture’s Food Safety and Inspection Service (FSIS) is issuing a public health alert for ready-to-eat (RTE) beef and chicken taquitos and chimichangas products containing Food and Drug Administration (FDA) regulated diced green chilies that have been recalled by the producer, Sun Valley Foods, due to concerns that the products may be contaminated with extraneous materials, specifically hard plastic. The hard plastic may pose a choking hazard or cause damage to teeth or gums . FSIS is issuing this public health alert out of the utmost of caution to ensure that consumers are aware that these products, which bear the USDA mark of inspection, should not be consumed.   The frozen RTE meat and poultry taquitos and chimichangas items were produced by Ajinomoto Foods North America, Inc. establishments in Lampasas, Texas, and San Diego, California. The following products are subject to the public health alert:  
  • 19.2-oz. carton containing 16 pieces labeled as “Great Value Flour Chicken Taquitos Tortillas Stuffed with All White Chicken Meat & Monterey Jack Cheese” with a best if used by date of “11 JUL 2021” and “P5590” printed on the side panel.
 
  • 20-oz carton containing 20 pieces labeled as “CASA MAMITA BEEF TAQUITOS ROLLED IN CORN TORTILLAS” with a best by date of “26 JUN 2021” and “EST 5590” printed on the side panel.
 
  • 22.5-oz carton containing 15 pieces labeled as “CASA MAMITA CHICKEN AND CHEESE TAQUITOS ROLLED IN FLOUR TORTILLAS” with a best by date of “26 JUN 2021” and “P5590” printed on the side panel
 
  • 15-oz. carton containing 15 taquitos labeled as “JOSÉ OLÉ TAQUITOS CHICKEN AND CHEESE POLLO Y QUESO IN FLOUR TORTILLAS” with a best by date of “08 JUL 2021” or “18 JUL 2021,” and “P5590” printed on the side panel.
 
  • 20-oz. carton containing 20 taquitos labeled as “JOSÉ OLÉ TAQUITOS BEEF CARNE DE RES IN CORN TORTILLAS” with a best by date of “08 JUL 2021” and “EST 5590” printed on the side panel.
 
  • 22.5-oz carton containing 15 taquitos labeled as “JOSÉ OLÉ TAQUITOS CHICKEN AND CHEESE POLLO Y QUESO IN FLOUR TORTILLAS” with a best by date of “09 JUL 2021,” “14 JUL 2021” or “17 JUL 2021” and “P5590” printed on the side panel.
 
  • 55.5-oz carton containing 37 taquitos labeled as “JOSÉ OLÉ VALUE PACK TAQUITOS CHICKEN AND CHEESE POLLO Y QUESO IN FLOUR TORTILLAS” with a best if used by date of “15 JUL 2021” and “P5590” printed on the side panel.
 
  • 60-oz. carton containing 60 taquitos labeled as “JOSÉ OLÉ TAQUITOS BEEF CARNE DE RES IN CORN TORTILLAS” with a best if used by date of “9 JUL 2021” or “10 JUL 2021,” and “EST 5590” printed on the side panel.
 
  • 5-oz. individual plastic bag containing “JOSÉ OLÉ CHIMICHANGAS LOADED BEEF NACHO” with a best by date of “15 JUL 2021” and “EST. 17417” printed on the label.
  The products bear the establishment number “EST 5590,” “P5590” or “EST. 17417” printed on the packaging above the expiration date. These products were shipped to retail locations nationwide.   The problem was discovered by Ajinomoto Foods North America, Inc. when they identified pieces of hard plastic in their production process and in a barrel of diced green chilies that was received from their ingredients supplier, Sun Valley Foods. Sun Valley Foods initiated a recall of the green chilies with the FDA. As more FDA information becomes available, FSIS will update this public health alert.   There have been no confirmed reports of adverse reactions due to consumption of these products. Anyone concerned about an illness should contact a health care provider.    FSIS is concerned that some product may be in consumers’ freezers. Consumers who have purchased these products are urged not to consume them. These products should be thrown away or returned to the place of purchase.   Consumers with questions can contact Willis Hwang, consumer affairs manager at Ajinomoto Foods, at (855) 742-5011. Media with questions about the public health alert can contact Paul Taylor, Ajinomoto Foods corporate attorney, at (909) 477-4800.   Consumers with food safety questions can "Ask Karen," the FSIS virtual representative available 24 hours a day at AskKaren.gov or via smartphone at m.askkaren.gov . The toll-free USDA Meat and Poultry Hotline 1-888-MPHotline (1-888-674-6854) is available in English and Spanish and can be reached from 10 a.m. to 6 p.m. (Eastern Time) Monday through Friday. Recorded food safety messages are available 24 hours a day. The online Electronic Consumer Complaint Monitoring System can be accessed 24 hours a day at: http://www.fsis.usda.gov/reportproblem .  
###
NOTE: Access news releases and other information at FSIS’ website at http://www.fsis.usda.gov/recalls . Follow FSIS on Twitter at twitter.com/usdafoodsafety or in Spanish at: twitter.com/usdafoodsafe_es.
  USDA is an equal opportunity provider, employer and lender. To file a complaint of discrimination, write: USDA, Director, Office of Civil Rights, 1400 Independence Avenue, SW, Washington, DC 20250-9410 or call (800) 795-3272 (voice), or (202) 720-6382 (TDD). 
         
         

 

Attachment

USDA FSIS USDA Food Safety and Inspection Service 2027209113 press@fsis.usda.gov

Scroll down for more posts ▼

Top 10 Most Recent News Articles

UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 3

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 6

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 21

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 7

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 7

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 6

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 6

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 7

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 6

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading

Top 5 Most Recently Viewed Articles

AIP Realty Trust Announces Successful Non-Brokered Offering

Updated Category News Views 177

AIP Realty Trust's Financial Milestone Achieved AIP Realty Trust has made waves in the investment community by successfully finalizing the initial tranche of a significant non-brokered private placement. These efforts have brought in an impressive total of 7,260,000 Preferred Units—Series B Convertible, valued at US$0.50 each, resulting in gross proceeds of...

Continue Reading
Medtronic's BrainSense™ Receives CE Marking for Parkinson's Care

Updated Category News Views 499

Medtronic’s Innovative Approval for Parkinson's Treatment Medtronic plc (NYSE: MDT), a global leader in healthcare technologies, has achieved a significant milestone by receiving CE Mark approval for its BrainSense™ Adaptive deep brain stimulation (aDBS) system and the BrainSense™ Electrode Identifier (EI). This remarkable advancement introduces the world's first...

Continue Reading
Understanding the New Rating for abrdn Asia-Pacific Income Fund

Updated Category News Views 84

KBRA's Rating Insights on abrdn Asia-Pacific Income Fund Recently, KBRA has taken significant steps by assigning a new rating to the Series B Mandatory Redeemable Preferred Shares (MRPS) of abrdn Asia-Pacific Income Fund, Inc. (NYSE: FAX). This rating stands at 'AA-', illustrating the organization's confidence in the stability and security of these investment instruments....

Continue Reading
Protect Your Investment: Join the Applied Therapeutics Class Action

Updated Category News Views 156

Understanding the Class Action for Applied Therapeutics Investors As an investor in Applied Therapeutics, Inc. (APLT), you may have felt the financial impact of recent challenges the company has encountered. The firm is currently facing a class action lawsuit aimed at addressing securities fraud that adversely affected investors between specific dates. This situation is...

Continue Reading
Heritage Capital Group Facilitates Mittauer's Strategic Sale

Updated Category News Views 205

Heritage Capital Group Facilitates Mittauer's Strategic Sale Heritage Capital Group, Inc. ("Heritage"), a respected investment banking and financial advisory firm known for serving middle-market and emerging growth companies, has successfully guided its client, Mittauer & Associates, Inc. ("Mittauer"), through a significant transition in its business landscape. This...

Continue Reading